Danika Webb

Danika Webb is an experienced leader in managed markets and payer strategy within the pharmaceutical industry. Currently serving as Senior Director at BridgeBio since August 2023, Danika previously held key positions at Global Blood Therapeutics, where responsibilities included leading the US Payer team and implementing successful payer strategies for oral specialty therapeutics, achieving over 90% aggregate prior authorization approval rates. Danika's tenure at Actelion involved driving formulary access for specialty therapies, and prior roles at Shionogi Inc. included management of regional accounts and sales teams. Danika holds a Bachelor of Science degree in Chemistry and Biochemistry and Molecular Biology from the University of San Diego.